欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7602/002
药品名称Lanreotid SUN 90 mg Injektionslösung in einer Fertigspritze
活性成分
    • Lanreotide 90.0 mg
剂型Solution for injection in pre-filled syringe
上市许可持有人Sun Pharmaceuticals Germany GmbH Hemmelrather Weg 201 51377 Leverkusen Germany
参考成员国 - 产品名称Germany (DE)
Lanreotid SUN 90 mg Injektionslösung in einer Fertigspritze
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Denmark (DK)
      Lanreotid Sun
    • Hungary (HU)
    • Belgium (BE)
      Lanreotide SUN 90 mg oplossing voor injectie in een voorgevulde spuit
    • Czechia (CZ)
      Lanreotidum SUN 90 mg injekční roztok v předplněné injekční stříkačce
    • Netherlands (NL)
    • Romania (RO)
      Lanreotida Terapia 90 mg soluţie injectabilă în seringă preumplută
    • Ireland (IE)
    • Slovakia (SK)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
许可日期2024/10/24
最近更新日期2025/09/19
药物ATC编码
    • H01CB03 lanreotide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase